Syridex bio

At Syridex Bio, we believe that access to quality healthcare should not be determined by socioeconomic status, race, geography, or any other demographic signifiers. The World Economic Forum recently highlighted the growing role of the private sector in addressing health inequities globally, detailing the impact of private sector investments and initiatives in expanding access to healthcare, reducing health disparities, and advancing health equity.

It's heartening to see that businesses are recognizing the critical link between health and economic prosperity and taking action to promote health equity. From investing in new medical treatments to supporting public health initiatives, the private sector has the power to drive positive change and make a meaningful impact on people's lives. However, the WEF also notes that there's still a long way to go in terms of addressing health inequities and achieving true health equity.

Syridex is proud to be part of a growing movement of private sector leaders who are taking action to advance health equity. Let's work together to create a world where everyone has access to the care they need. You can read the full article here: https://lnkd.in/eYgQPCrX

Health equity: Your health outlook depends on where you live The World Economic Forum is committed to advancing health equity through its Global Health Equity Network, focused on building public-private sector coalitions to advance health equity.

In honor of MLK Day 2023, Buchanan is pleased to invite you to a webinar "Social Justice in Healthcare: Addressing Health Disparities and Unequal Access." The program will feature Manoj K.Raghunandan…...

Social Justice in Healthcare: Addressing Health Disparities and Unequal Access In honor of MLK Day 2023, Buchanan is pleased to invite you to a webinar "Social Justice in Healthcare: Addressing Health Disparities and Unequal Access." The program will feature Manoj K. Raghunandan…

For Life Sciences investing Contact us at [email protected] or visit at 300 Carnegie Center, Suite 150, Princeton, NJ 08540.

Syridex Bio I Contact [email protected] 300 Carnegie Center, Suite 150, Princeton, NJ 08540

Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity
Impact investment firm focuses on investing in therapies for diseases that disproportionately affect underserved populations, including ethnic minorities.

News insights I Syridexbio Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity Impact investment firm focuses on investing in therapies for diseases that disproportionately affect underserved populations, including ethnic minorities

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities and invest along two primary strategies venture creation and private equity.

Syridex Bio I Investment Approach Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. We draw on our deep relationships across the global pharmaceutical and biotech industries to source innovative, best-in-clas ...

Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep health inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow.

Syridex Bio I About us Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far ...

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities - we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.

Home I Accelerating Health Equity

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that address the needs of underserved communities.

Social Justice in Healthcare: Addressing Health Disparities and Unequal Access In honor of MLK Day 2023, Buchanan is pleased to invite you to a webinar "Social Justice in Healthcare: Addressing Health Disparities and Unequal Access." The program will feature Manoj K. Raghunandan…

Did you know that breast cancer disproportionally affects women of color in the United States? Specifically, Triple Negative Breast Cancer (TNBC) is of concern for Black and Hispanic populations. These groups are more likely to be diagnosed with this aggressive cancer, and to have a higher mortality rate, compared to non-Hispanic white women. At Syridex Bio, our mission is to identify health inequities, such as those surrounding TNBC, and to invest in therapies that help close the gap among these underserved communities. Learn more about health inequities related to TNBC here: &

Triple-negative breast cancer highlights the need Syridex Bio Did you know that breast cancer disproportionally affects women of color in the United States? Specifically, Triple Negative Breast Cancer (TNBC) is of concern for Black and Hispanic populations. T…

https://syridexbio.wordpress.com/

Syridex Bio Investing in Therapies that Accelerate Health Equit

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities.

Syridex Bio is an impact-driven Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. We are filling this gap i…

Syridex bio

Syridex Bio new jersey, New Jersey Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep … view this ad now!

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities.

Advancing health equity Syridex Bio Advancing health equity’ is a trendy concept in the healthcare industry right now, and many organizations trying to move the needle on change in this space have been turning to increased data colle…

Advancing health equity’ is a trendy concept in the healthcare industry right now, and many organizations trying to move the needle on change in this space have been turning to increased data collection and analysis as the first step forward. However, healthcare systems and organizations are already armed with enough data to begin making impactful change, as Forbes notes in a recent article.

At Syridex Bio, we are actively working to address health inequities by investing in therapies to treat diseases that disproportionately affect minority populations, effectively filling a gap in the healthcare market to provide access and treatment options for historically underserved communities. Read the Forbes article to learn how taking actionable steps now can advance progress toward health equity:
https://lnkd.in/ex_puw6W & https://www.syridexbio.com/

Everyone deserves the opportunity to live a healthy life. However, according to this recent World Economic Forum article, up to 70% of health outcome disparities are due to non-medical drivers of health – including factors like financial security, housing, and other social, economic, and environmental pressures. With this frame of reference, every company can contribute to advancing health equity by providing the benefits necessary for a healthy life, ensuring its offerings…...

Everyone deserves the opportunity to live a healthy life Everyone deserves the opportunity to live a healthy life. However, according to this recent World Economic Forum article, up to 70% of health outcome disparities are due to non-medical drivers of h…

Everyone deserves the opportunity to live a healthy life. However, according to this recent World Economic Forum article, up to 70% of health outcome disparities are due to non-medical drivers of health – including factors like financial security, housing, and other social, economic, and environmental pressures. With this frame of reference, every company can contribute to advancing health equity by providing the benefits necessary for a healthy life, ensuring its offerings lead to equitable outcomes, and investing in community initiatives.

Recognizing this relationship between medical and non-medical factors affecting health, the CVS Health Foundation, for example, has invested $185 million in affordable housing in underserved communities to support health equity, while the Novo Nordisk Group has worked with more than 40 cities worldwide to address the systemic issues underlying obesity and type 2 diabetes. Read the full article to learn how every company can accelerate corporate action towards addressing health inequities: https://www.syridexbio.com/

Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow.

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.

At this point, no one should be surprised by the vast disparities in the American healthcare system. In 1985, the Department of Health and Human Services published what is now referred to as the Heckler Report, a landmark study that quantified the gap between health outcomes of white populations and those of minority communities across the United States. As a result of those findings, awareness spread of this deeply embedded systemic problem.

The current reality is that awareness, at least on its own, has stimulated little change. Accelerating progress toward health equity will require unified action by a range of leaders and stakeholders, and it is increasingly clear that the investor community must play a central role. Read Managing Partner Squire Servance’s article, Social Justice in Healthcare: The Disparities Signify the Investment Opportunity, to learn more about accelerating health equity:
https://lnkd.in/e68J5xbU & https://www.syridexbio.com/

Social Justice in Healthcare By Squire Servance, Founder & Managing Partner of Syridex Bio The evidence documenting vast disparities across the American healthcare system is plentiful – and at this point, it should surprise no one. Back in 1985, the Department of Health and Human Services published what today is referre ...